Veru to participate in the virtual btig obesity health forum

Miami, fl, june 11, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company will be participating in one-on-one meetings and a fire side chat presentation with investors at the virtual btig obesity health forum on june 18, 2025.
VERU Ratings Summary
VERU Quant Ranking